Cas:608527-58-8 N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine manufacturer & supplier

Chemical Name:N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine

CAS.NO:608527-58-8

Synonyms:3,6-bis(diphenylamino)-9H-carbazole;3,6-bis(N-diphenylamino)-9H-carbazole;N,N,N’,N’-tetraphenyl-9H-carbazole-3,6-diamine

Molecular Formula:C₃₆H₂₇N₃

Molecular Weight:501.62000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:22.27000

Exact Mass:501.22000

LogP:10.26070

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,6-bis(diphenylamino)-9H-carbazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N,N’,N’-tetraphenyl-9H-carbazole-3,6-diamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,6-bis(diphenylamino)-9H-carbazole Use and application,N,N,N’,N’-tetraphenyl-9H-carbazole-3,6-diamine technical grade,usp/ep/jp grade.

Related News: A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine manufacturer However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine supplier An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug. N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).